Government Gazette Republic of Namibia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Benetton Group Spa Rating Change UNDERPERFORM
Benetton Group Spa Rating Change UNDERPERFORM Equity | Italy | Apparel 15 November 2010 Faded colours Flavio Cereda >> +44 20 7996 1455 Research Analyst MLPF&S (UK) Downgrading BEN to Underperform: PO cut 17% to €5.0 [email protected] We believe BEN has become a value trap, we thought the stock had reached a floor of sorts after H110: it does not appear so. A poor Q3 combined with deteriorating news flow has returned the stock to its previous predicament, in our Stock Data view: how do I deal with competitors that are bigger, better and more appealing Price EUR5.10 than me? BEN’s inability to generate any real growth this year in spite of the Price Objective EUR5.00 recent restructuring effort (mgmt estimate €50mn net benefits at the EBIT level as Date Established 15-Nov-2010 a result) and peer performance, flags a troubling lack of brand appeal, in our view, Investment Opinion B-3-7 Volatility Risk MEDIUM that we fear will take some time to redress given a challenging 2011-12. 52-Week Range EUR5.06-EUR6.97 Beyond cotton…between a rock and a hard place… Mrkt Val / Shares Out (mn) EUR931 / 182.7 We think BEN will be struggling with a number of very key issues in the MT: over- Average Daily Volume 297,628 reliance on a stagnant and increasingly competitive domestic market (46%), BofAML Ticker / Exchange BNTOF / MIL Bloomberg / Reuters BEN IM / BNG.MI soaring input costs (a first toll in Q4-10 and H1-11), the need to continue to run a ROE (2010E) 7.4% ‘nice price’ policy with many of its retail clients, relatively small exposure to Asia Net Dbt to Eqty (Dec-2009A) 38.4% (16%) and China in particular, and what appears to be a troubling lack of profile in Est. -
Beecham Group PLC and Another V Triomed (Pty) Ltd [2002] 4 All SA 193 (SCA)
Beecham Group PLC and another v Triomed (Pty) Ltd [2002] 4 All SA 193 (SCA) Division: Supreme Court of Appeal Date: 19 September 2002 Case No: 100/01 Before: Harms, Scott, Mpati, Conradie JJA and Jones AJA Sourced by: PR Cronje Summarised by: D.Harris Parallel Citation: 2003 (3) SA 639 (SCA) . Editor's Summary . Cases Referred to . Judgment . [1] Intellectual property Trade marks Registration of shape as trade mark Where shape is not intended to be used to distinguish owner's products from those of another, it cannot be regarded as a trade mark Application for expungement from trade marks register therefore allowed. Editor's Summary Both parties involved in the present matter were players in the pharmaceutical industry. The Appellants sought the upholding of a trade mark for the shape of a tablet, and a finding that the Respondent had infringed the trade mark. The Respondent imported a tablet with the same composition and shape as that of the Appellants. In the court a quo, the Respondent applied for the expungement from the trade mark register of the shape trade mark. The Appellants launched a counterapplication for relief for trade mark infringement. The latter application failed while that of the Respondent succeeded. Held Interested parties may apply to court for the removal of an entry wrongly made or remaining on the trade mark register. The first question posed by the Court was whether the Appellants' shape mark constituted a trade mark in terms of section 10(1) of the Trade Marks Act 194 of 1993 ("the Act"). -
Annual Report 2004
04 Bringing growth into focus. Annual Report 2004. 04 a successful year for Continental. 2 2 Continental Corporation in € millions 2004 2003 2002 2001 2000 Sales 12,597.4 11,534.4 11,408.3 11,233.3 10,115.0 EBITA¹ 1,096.4 855.2 694.3 32.8 533.0 Consolidated net income/loss for the year 673.8 314.0 226.0 - 257.6 204.7 Dividends 116.3² 70.4 58.6 – 64.1 Cash flow 1,443.8 985.9 919.0 666.5 866.3 Capital expenditure on property, plant, and equipment 672.4 583.5 581.2 704.9 682.8 Amortization and depreciation³ 665.7 603.1 670.3 891.3 654.7 Shareholders’ equity 2,842.3 1,983.2 1,715.2 1,546.7 1,844.1 Equity ratio in % 29.4 23.9 20.9 17.2 24.2 Employees at the end of the year 4 80,586 68,829 64,379 65,293 63,832 Share price (high) in € 47.26 30.98 19.53 19.45 20.94 Share price (low) in € 28.87 12.04 11.72 9.68 15.85 ¹ Earnings before interest, taxes and regular goodwill amortization ² Subject to the approval of the Annual Shareholders’ Meeting on May 12, 2005 ³ Excluding write-downs of investments 4 Excluding trainees Continental Divisions Sales in € millions 2004 2003 Automotive Systems 5,007.7 4,625.7 Passenger and Light Truck Tires 4,104.2 3,907.2 Commercial Vehicle Tires 1,500.7 1,261.6 ContiTech 2,063.4 1,812.2 EBIT in € millions 2004 2003 Automotive Systems 487.5 369.5 Passenger and Light Truck Tires 383.4 345.8 Commercial Vehicle Tires 100.3 82.4 ContiTech 150.4 144.0 Bringing growth into focus. -
List of Section 13F Securities
List of Section 13F Securities 1st Quarter FY 2004 Copyright (c) 2004 American Bankers Association. CUSIP Numbers and descriptions are used with permission by Standard & Poors CUSIP Service Bureau, a division of The McGraw-Hill Companies, Inc. All rights reserved. No redistribution without permission from Standard & Poors CUSIP Service Bureau. Standard & Poors CUSIP Service Bureau does not guarantee the accuracy or completeness of the CUSIP Numbers and standard descriptions included herein and neither the American Bankers Association nor Standard & Poor's CUSIP Service Bureau shall be responsible for any errors, omissions or damages arising out of the use of such information. U.S. Securities and Exchange Commission OFFICIAL LIST OF SECTION 13(f) SECURITIES USER INFORMATION SHEET General This list of “Section 13(f) securities” as defined by Rule 13f-1(c) [17 CFR 240.13f-1(c)] is made available to the public pursuant to Section13 (f) (3) of the Securities Exchange Act of 1934 [15 USC 78m(f) (3)]. It is made available for use in the preparation of reports filed with the Securities and Exhange Commission pursuant to Rule 13f-1 [17 CFR 240.13f-1] under Section 13(f) of the Securities Exchange Act of 1934. An updated list is published on a quarterly basis. This list is current as of March 15, 2004, and may be relied on by institutional investment managers filing Form 13F reports for the calendar quarter ending March 31, 2004. Institutional investment managers should report holdings--number of shares and fair market value--as of the last day of the calendar quarter as required by Section 13(f)(1) and Rule 13f-1 thereunder. -
Benetton Colours Debut in Printemps Haussmann, Iconic Shopping Destination in Paris
BENETTON COLOURS DEBUT IN PRINTEMPS HAUSSMANN, ICONIC SHOPPING DESTINATION IN PARIS United Colors of Benetton continues to expand its distribution network, bringing the premium level collections to the most prestigious department stores Ponzano Veneto, 30th August 2019 - After partnering with London’s Selfridges, an historic address for international shopping, Paris temple of shopping Printemps Haussmann, has also chosen the United Colors of Benetton collections. On the third floor of the department store - located in the heart of Paris, on Boulevard Haussmann - Benetton Group has inaugurated the new United Colors of Benetton space. Dedicated entirely to women, the new corner inside the prestigious location will host the garments of the Fall- Winter 2019/2020 collection by Jean-Charles de Castelbajac, artistic director of the brand since October 2018. A celebration of the brand's DNA, in which colourful energy, Italian knitwear expertise, creative details and sporty-chic spirit mix together and bring a contemporary, pop universe to life. The Benetton space inside Printemps Haussmann, covering an area of 200 square metres, is divided into two areas: one dedicated to the premium collections, the other housing knitwear garments that give life to a great colour theatre. The two areas are connected by coloured threads that recall the characteristic “stitch” of the United Colors of Benetton logo, located at the entrance of the Benetton area. The coloured thread extensions radiate into the space, taking various forms and directions: starting as hanging rails to display the collection, they transform into multi-coloured paths that lead to the Benetton garments displayed in the "Color Theatre", where the iconic knitwear line is celebrated. -
Explaining Corporate Success Abstract
Explaining corporate success: Britain’s best performing firms, 1949-1985 D.M. Higgins, S. Toms The York Management School Abstract The paper synthesises theories of competitive advantage in a dynamic framework to explain the determinants of corporate success. A model is presented linking the firm’s resource audit and dynamic capabilities with the rate of market growth. For the purposes of testing the model, an examination of the performance of all British quoted companies during the period is conducted with reference to achieved long run average rates of return on capital employed. The best performing firms are analysed in more detail and their strategies mapped according to the model criteria. Conclusions are then drawn on the possible strategies for achieving long run corporate success in terms of above average financial returns. Correspondence Steven Toms Joint Editor: Business History Professor of Accounting and Finance and Head of School The York Management School Sally Baldwin Buildings University of York York YO10 5DD Tel: (44) 1904-434122 Fax: (44) 1904-433 431 Email: [email protected] http://www.york.ac.uk/management/staff/StaffProfiles/SToms.htm 1 Explaining corporate success: Britain’s best performing firms, 1949-1985 1. Introduction Competitive advantage and more specifically sustained competitive advantage and its determinants, has become an important research topic in the business and management and industrial organisation literatures. Sustained competitive advantage (SCA) implies not just achieving superior returns, but achieving them over a protracted period of time. It is therefore surprising that the overwhelming majority of this literature has not explored the notion of sustained competitive advantage from a historical perspective. -
Glaxosmithkline Plc Annual Report for the Year Ended 31St December 2000
GlaxoSmithKline 01 GlaxoSmithKline plc Annual Report for the year ended 31st December 2000 Contents Report of the Directors 02 Financial summary 03 Joint statement by the Chairman and the Chief Executive Officer 05 Description of business 29 Corporate governance 37 Remuneration report 47 Operating and financial review and prospects 69 Financial statements 70 Directors’ statements of responsibility 71 Report by the auditors 72 Consolidated statement of profit and loss 72 Consolidated statement of total recognised gains and losses 74 Consolidated statement of cash flow 76 Consolidated balance sheet 76 Reconciliation of movements in equity shareholders’ funds 77 Company balance sheet 78 Notes to the financial statements 136 Group companies 142 Principal financial statements in US$ 144 Financial record 153 Investor information 154 Shareholder return 156 Taxation information for shareholders 157 Shareholder information 158 Share capital 160 Cross reference to Form 20-F 162 Glossary of terms The Annual Report was approved by the Board 163 Index of Directors on 22nd March 2001 and published on 12th April 2001. Contact details 02 GlaxoSmithKline Financial summary 2000 1999 Increase Business performance £m £m CER % £ % Sales 18,079 16,164 9 12 Trading profit 5,026 4,378 12 15 Profit before taxation 5,327 4,708 11 13 Earnings/Net income 3,697 3,222 13 15 Earnings per Ordinary Share 61.0p 52.7p 14 16 Total results Profit before taxation 6,029 4,236 Earnings/Net income 4,154 2,859 Earnings per Ordinary Share 68.5p 46.7p Business performance: results exclude merger items and restructuring costs; 1999 sales and trading profit exclude the Healthcare Services businesses which were disposed of in 1999. -
Division of Investment Department of the Treasury State of New Jersey Pension Fund June 30, 2009 and 2008 (With Independent Auditors’ Report Thereon)
F INANCIAL S TATEMENTS, M ANAGEMENT’ S D ISCUSSION AND A NALYSIS AND S UPPLEMENTAL S CHEDULES Division of Investment Department of the Treasury State of New Jersey Pension Fund June 30, 2009 and 2008 (With Independent Auditors’ Report Thereon) Division of Investment Department of the Treasury State of New Jersey Pension Fund Financial Statements June 30, 2009 and 2008 Contents Independent Auditors’ Report ..........................................................................................................1 Management’s Discussion and Analysis .........................................................................................3 Basic Financial Statements: Statements of Net Assets .................................................................................................................7 Statements of Changes in Net Assets...............................................................................................8 Notes to Financial Statements ..........................................................................................................9 Supplemental Schedules: Schedule 1 – Combining Schedule of Net Assets ..........................................................................31 Schedule 2 – Combining Schedule of Changes in Net Assets .......................................................32 Schedule 3 – Portfolio of Investments – Common Fund A ...........................................................33 Schedule 4 – Portfolio of Investments – Common Fund B ...........................................................57 -
Marco Boglione and Adriano Moraglio
People on the Move Marco Boglione and Adriano Moraglio Slowly please, I’m in a hurry Entrepreneur is cool! Basic Edizioni All rights reserved © 2009 Marco Boglione and Adriano Moraglio, Torino Original title «Piano piano che ho fretta» Printed in Torino, Italy Release 1.1.1 English translation by Daniel Monti ISBN 978-88-905499-1-5 To our children FOREWORD A corrispondence A friendship Marco and I have known each other for some time. I started to take an interest in him as a journalist when he was filling institutional posts, to be precise from the time he became president of Film Commission and later took up the same post for ITP (Investment in Turin and Pied- mont), the Agency devoted at the time to attracting foreign investors to Piedmont. When I met him I liked him immediately. Moreover it was clear that he had decided to offer his experience as an entrepreneur to a public body for a set period without seeking any profit whatsoever, profit being the purpose of any entrepreneurial venture. In spring 2008 I fancied a chat with him again so I set up a meeting. I did not have to interview him for my newspaper or gather information on his group, BasicNet, owner of the famous Kappa, Robe di Kappa, Jesus Jeans, Superga, K-Way brands. The last time I had seen him it had been at a jazz evening I had organized: he attended with his “wife” Stella (I’ll explain the meaning of the in- verted commas later). I told him I loved pizza and he invited me to that extraordinary pizzeria known as Fratelli La Cozza, behind BasicNet’s headquarters in Torino, under the very roof that saw the dawn of local industrial activity in 1916, when Abramo Vitale – a second name that will play a fundamental part in Marco Boglione’s existence – established Società Anonima Calzificio Torinese. -
2019 Consolidated Financial Statements
CONSOLIDATED 2019 FINANCIAL STATEMENTS CONSOLIDATED 2019 FINANCIAL STATEMENTS CONTENTS 5 Group key data 6 Parent Company officers 7 Group activities 8 Group chart 9 Financial highlights 10 Net Asset Value 11 Directors’ report 12 Analysis of the consolidated financial statements 19 Human resources 21 Performance by business segment 65 Additional information 67 Consolidated financial statements at December 31, 2019 68 Consolidated statement of financial position 70 Consolidated income statement 71 Consolidated statement of comprehensive income 72 Consolidated statement of changes in shareholders’ equity 73 Consolidated cash flow statement 75 Notes to the consolidated financial statements 155 Annexes 156 List of consolidated companies at December 31, 2019 170 Report of the independent auditors EDIZIONE 3 GROUP KEY DATA EDIZIONE 5 PARENT COMPANY OFFICERS 1 5 Board of Directors General Manager Gianni Mion 2 Carlo Bertazzo Chairman Alessandro Benetton 5 Resigned on February 29, 2020. Director Christian Benetton Director Franca Bertagnin Benetton Director Board of Statutory auditors Sabrina Benetton Angelo Casò Director Chairman Carlo Bertazzo Giovanni Pietro Cunial Director Aldo Laghi Auditors Giovanni Costa Director Alberto Giussani Maria Martellini 6 Fabio Cerchiai 3 Alternate auditors Director Fabio Buttignon 4 6 Alternate Auditor whose term of office ended on May 25, 2020. Director Marco Patuano 4 Director 1 Appointed on June 24, 2019. In office until approval of the financial statements at December 31, 2019 2 Appointed Chairman on June 24, 2019. 3 Chairman whose term of office ended on June 24, 2019. 4 Director whose term of office ended on June 24, 2019. Independent auditors Deloitte & Touche S.p.A. In office until approval of the financial statements at December 31, 2019 In office until approval of the financial statements at December 31, 2023 6 EDIZIONE GROUP KEY DATA GROUP ACTIVITIES At December 31, 2019 Edizione S.r.l. -
Benetton Group
Gruppo Banca Leonardo June 23 2009 Benetton Group UNDERWEIGHT A fancy color diamond Target price €5.4 (from previous TP €5.0) Benetton Group is one of the main global players in the apparel business, present Current price €6.3* in 120 countries with over 6,200 stores and five brands. In 2008 the business was *Price as of June 18 2009 re-focused on four strategic priorities: 1) accelerating expansion in five key emerging countries; 2) pursuing growth in consolidated markets; 3) developing Outstanding shares (m) new commercial initiatives; 4) evolving the culture of the organization. Starting 183 from 2008 the company has also adopted a new approach focused on the final Mkt. Cap.(€m) consumer, leveraging on the wholesale business model with a sell-out approach. 1,156 Due to the changed economic environment the company also adopted in 2009 a Avg. daily volumes (30 days) reorganization plan focused on boosting the commercial business, on optimizing 251,600 shares the supply chain and costs, and on cash generation, aimed at motivating the Main shareholders network and re-thinking the supply chain processes to create a lower cost base. Edizione 67.1% Even if we appreciate the reorganization plan and the new company approach to Reuters / Bloomberg the market, we remain cautious given the low visibility on future consumer trends. BEN.MI / BEN IM UNDERWEIGHT with a €5.4 target price. Last 12 months Catalysts High: €8.3 Low: €4.4 1) Unfavourable macroeconomic conditions; 2) pressure on sales and margins; 3) business proposition "quality at an accessible price"; 4) new sell-out approach; 5) reorganization plan; 6) potential new consumers from trading-down trend; 7) new commercial initiatives (i.e. -
A Thesis Entitled an Oral Dosage Form of Ceftriaxone Sodium Using Enteric
A Thesis entitled An oral dosage form of ceftriaxone sodium using enteric coated sustained release calcium alginate beads by Darshan Lalwani Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences with Industrial Pharmacy Option _________________________________________ Jerry Nesamony, Ph.D., Committee Chair _________________________________________ Sai Hanuman Sagar Boddu, Ph.D, Committee Member _________________________________________ Youssef Sari, Ph.D., Committee Member _________________________________________ Patricia R. Komuniecki, PhD, Dean College of Graduate Studies The University of Toledo May 2015 Copyright 2015, Darshan Narendra Lalwani This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of An oral dosage form of ceftriaxone sodium using enteric coated sustained release calcium alginate beads by Darshan Lalwani Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Science Degree in Pharmaceutical Sciences with Industrial Pharmacy option The University of Toledo May 2015 Purpose: Ceftriaxone (CTZ) is a broad spectrum semisynthetic, third generation cephalosporin antibiotic. It is an acid labile drug belonging to class III of biopharmaceutical classification system (BCS). It can be solvated quickly but suffers from the drawback of poor oral bioavailability owing to its limited permeability through